The Aspira® Advantage, Transforming Home Drainage into Compassionate Care

The Aspira® Advantage, Transforming Home Drainage into Compassionate Care

Merit Medical® products and services ensure that patient care is compassionate care. The Aspira® Home Drainage System—a palliative care product designed to help patients with malignant pleural effusions and ascites drain fluid in the comfort of their own home—is a prime example. With the help of Aspira, patients can manage symptoms without repeated and often difficult trips to the hospital. Combined with 24/7 ongoing support from an expert customer service team, the Aspira system gives patients a gentler and more efficient approach to home drainage. All this and more is what Merit likes to call the Aspira Advantage.

It starts with a superior product, the Aspira Home Drainage System, which features a 15.5F indwelling catheter with attachable valve made to drain accumulated fluid into lightweight, 1-liter bags. To begin draining, the Aspira system requires no complex set up; the drainage line connects easily to the drainage bag, and with one gentle squeeze of the pump, drainage begins.

Built to enhance the patient experience, the Aspira system minimizes discomfort and challenges that can often be associated with drainage. Its gravity-based design produces a low, consistent vacuum pressure flow, which can reduce pain seen with high-vacuum suction methods of other systems.

Simulated testing1 shows that with 67% more fenestrations and a 72% larger valve, the Aspira system can comfortably complete drainage in less than 15 minutes—68% faster than other systems—and all within the comfort of home.

Choosing Aspira means benefits to the physician as well, including product options that increase flexibility of patient care. The Aspira system is designed with three different placement options (antegrade, retrograde, and over-the-wire) and various kit configurations to accommodate patient and customer needs.The Aspira® Advantage, Transforming Home Drainage into Compassionate Care

Switching from hospital drainage to home drainage with the Aspira system is also cost effective in many ways. Aspira bags are less bulky, and they are easier to transport and store in homes, hospitals, and post-care facilities. Comparative data1 show that one box of four bottles and dressings require approximately the same space as 20 Aspira bags and dressings, or 68% less storage space.

Another advantage to choosing the Aspira system is the ongoing customer service that Merit offers patients and providers. The Compassionate Care Program supports patients with Aspira supplies, delivered right to their homes, even for those without health insurance.

In-servicing and home health training is available as well as opportunities for written feedback on the Aspira system, flexibility in shipping, and assistance with reimbursement. Print and online educational materials are available at MyAspira.com, a site tailored to both patients and providers. If patients or customers want one-on-one help, a highly trained customer service team is ready to assist 24/7 through the dedicated Aspira Hotline (1-800-356-3748).

Let Merit help you transform home drainage into compassionate care with the Aspira Advantage. Explore everything it can offer by visiting MyAspira.com, or reach out to the customer service team today to receive a patient demo kit and hear more about the training opportunities it provides.

Learn more about the product, including its instructions for use and important product safety information, by visiting the Aspira Drainage System product page.


REFERENCES

  1. Data on file.
ReSolve ConvertX Limits Risk Exposure for Your Patients - Merit Medical - Stent Systems

ReSolve ConvertX® Simplifies Drainage Care, Limits Patient Exposure

ReSolve ConvertX Limits Risk Exposure for Your Patients - Merit Medical - Stent Systems

To limit coronavirus exposure to patients and healthcare workers, healthcare facilities are decreasing the number of procedures performed as well as the length of procedure time for those that remain scheduled. This includes replacing surgical care with less-invasive interventional radiology procedures.

New hospital protocols may prove challenging for patients who need multistep care, as seen with individuals who suffer with severe ureteral or biliary obstructions. Traditionally, these patients require two separate interventional procedures to successfully place a temporary internal drainage: a first procedure to place a drainage catheter and a second to place a stent.

To simplify treatment for these patients, Merit Medical offers a temporary internal nephroureteral and biliary drainage stent system called the ReSolve ConvertX Stent System. A less-invasive option than conventional treatment, the ReSolve ConvertX completely eliminates the need for a second drain-to-stent procedure. Instead, stent conversion can be done in an office or at bedside in less than one minute.1

 

ReSolve ConvertX - Minimally Invasive, Reduces Patient and Provider Risk, Limits Exposure - Merit Medical

WATCH HOW THE RESOLVE CONVERTX WORKS

Simplifies Treatment - Resolve ConvertX

Eliminating a second interventional procedure has several advantages, particularly in the present healthcare crisis. Without the need for a lengthy, additional drain-to-stent procedure, hospital visits may be shorter for patients,2 potentially resulting in less risk of exposure to other patients, physicians, and hospital staff. Because treatment with the ReSolve ConvertX can be completed in a less-intense care setting, it can free up physicians and hospital staff to care for an increasing caseload outside of the interventional radiology suite. This may also leave the interventional radiology suite open for an influx of new interventional cases.

Reduces Exposure - Resolve ConvertX

The ReSolve ConvertX is also designed with other clinical benefits in mind, such as reduced procedural challenges for the patient. Furthermore, with fewer procedures, there is less radiation exposure for patients, physicians, and hospital staff.

FIRST IMPRESSIONS OF RESOLVE CONVERTX

The Impact of COVID-19 on Breast Cancer Management

 

SCOUT Localization can help alleviate future workflow challenges

As a result of the effect of the COVID-19 pandemic in the US, screening, diagnostic exams, and surgical procedures are being severely restricted or postponed at hospitals and breast centers across the country. This is causing a disruption never experienced before in the diagnosis and treatment of the 325,000 projected cases of breast cancer in 2020 in the US.1

These delays and closures will impact care delivery well into the foreseeable future. While this health crisis clearly needs immediate management, we also need to think long term on how to effectively manage the backlog of breast cancer patients once restrictions have been lifted.

Merit Oncology is connecting physicians across the county to share their experiences, challenges, and solutions with managing breast patients during COVID-19. Merit Café is a forum for healthcare providers to come together to share best practices and experiences in an online, interactive forum moderated by a radiologist and a surgeon. Discussion focuses on relevant topics including triaging breast patient care during the COVID-19 pandemic, procedure efficiency, minimizing patient/provider exposure, and planning for downstream challenges anticipated post-pandemic.

Joining Merit for this Q&A is Vincent Reid, MD, Surgical Oncologist at Mercy’s Hall-Perrine Cancer Center, Cedar Rapids, Iowa and one of the first moderators of Merit Café

Does your institution have guidelines established for the surgical management of breast cancer patients?

There has been guidance published from different organizations and societies on the management of elective surgeries. It is important to note that they all share the common goal of minimizing patient and physician exposure and preserving personal protective equipment (PPE). The guidelines are mostly based on the assumption of a low to moderate COVID-19 census at your facility. Once a surge of COVID-19 occurs, the guidelines become more restrictive. The guidelines are also constantly being updated, so it is important to stay on top of the latest revisions.

At the current time, in our community, we are at that low to moderate stage. However, as I talk to colleagues on Merit Café from other parts of the country, particularly on the East coast, their situation is very different. Having the opportunity to learn what they are doing has been helpful to me in planning for different scenarios.

Access the most recent guidelines from the COVID-19 Pandemic Breast Cancer Consortium, comprised of representatives from the American Society of Breast Surgeons (ASBrS), the National Accreditation Program for Breast Centers (NAPBC), the National Comprehensive Care Network (NCCN), the Commission on Cancer (CoC), and American College of Radiology (ACR) here.

Based on your hospital’s and your region’s exposure, what are some of the plans you are putting into place now to help patients and staff when restrictions are lifted at your hospital?

Our number one priority is to help ease the stress and anxiety of our patients during this difficult time, not only about their cancer but now COVID-19. All our breast cancer patients are being evaluated by a multidisciplinary group to develop a recommended care plan. Some patients are having surgery delayed and for those patients where it is appropriate, they are going to either neoadjuvant chemotherapy (NAC) or endocrine therapy prior to surgery. We are localizing these patients with SCOUT®, which can safely and effectively be placed, even though they will not go surgery for several months. This will streamline the process once they are ready to go to surgery. If immediate surgery is indicated those patients proceed to surgery.

Where appropriate, we are also localizing with SCOUT at time of biopsy. At Mercy, a number of our patients drive long distances for treatment. When we can eliminate an entire procedure, we eliminate a travel day, decrease patient and physician interaction, and preserve PPE. That is significant all around.

How do you anticipate the strategies you are implementing now will help with overrun schedules in all hospital departments?

I see two things, first the placement of SCOUT in our surgical patients. Our radiology department is going to be slammed just catching up with routine mammography screening. Patients who have been waiting for cancer surgery for 2-4 months are not going to want to wait any longer than needed if they have to go and be localized prior to surgery. They will get very impatient if radiology scheduling resulted in an additional delay.

The second is telemedicine. Our cancer program was about two years out on the horizon for implementing a meaningful telemedicine program. Now fast forward to a pandemic and we have progressed leaps and bounds in this implementation. We are conducting video telemedicine consultations with patients now, so they do not have to be delayed waiting for a consult. It is an excellent tool and allows me quality time with my patients discussing options.

Have you seen any unexpected outcomes of the COVID-19 restrictions?

I am seeing more patients opting for a lumpectomy over mastectomy. Clearly there are clinical cases where a mastectomy is the only option, but with the current surgical restrictions we are not able to do reconstruction – that part of the procedure is being delayed. Women who are candidates for lumpectomy, who were leaning toward a mastectomy of their own choice are now opting for a lumpectomy.

The outcome that I find most enlightening is that we are all united in a powerful way. I am virtually connecting with colleagues, that I might have never had the opportunity to meet, and we are sharing and learning from each other. I look forward to the day our medical societies come together again, and we can all meet in person.

What are you telling your breast cancer patients during this difficult time?

I think the most important message for patients is the reassurance that no matter what the recommended course of treatment is they are not being put at risk. We are thoughtfully evaluating all the options, and even in the COVID-19 environment as we are working to keep everyone safe, we are not compromising their cancer care. I also reassure them that once restrictions are lifted everything possible has been done to assure, they can move on to the next step of treatment as quickly as possible.

Merit Medical Products Support Cutting-Edge Medical Training

Merit Medical Products Support Cutting-Edge Medical Training

Merit Medical Products Support Cutting-Edge Medical Training V2

At the Imperial College London, future interventional radiologists are sharpening their biopsy skills by attending educational workshops that use a newly developed medical simulation. The cutting-edge technology, called the Microsoft HoloLens 2, operates through interactive holograms that allow junior trainees to practice using augmented reality headsets.

The comprehensive workshop provided trainees with several stations where they could practice simulations of image-guided needle biopsy. Trainees at HoloLens 2 simulation stations used the Merit CorVocet® Biopsy System to help create a combination of “real” and “virtual” elements. Other Merit biopsy needles were employed at additional hands-on ultrasound workshop stations.

The simulation was developed by a team of experts from Imperial’s Faculty of Medicine and Digital Learning Hub, a team that works with students and teachers to create innovative learning and teaching experiences using augmented reality and virtual reality. Its mission is to create interactive, challenging, and authentic digital education.

“By building the simulation in mixed reality, it not only allows for accurate imaging placement but also for crucial tactile feedback,” explained Mohamad Hamady, a professor in the department of Surgery & Cancer at the Imperial College London and part of the team that developed the simulation. “It’s constructed from real patient X-rays, and they are using real needles.”

Image-guided interventions, particularly those using computed tomography (CT) imaging, are traditionally taught using a mentored approach on real patients or in costly cadaver workshops.

“This app really demonstrates the potential of mixed reality to provide high-fidelity experience at a fraction of the cost of traditional methods. It is readily scalable, and I am sure will form part of the training for doctors in the future,” noted Dimitri Amiras, MBBS, BSc, a musculoskeletal consultant radiologist at Imperial College Healthcare NHS Trust and part of the team that developed the simulation. “As technology improves this will not only change the way we train but also the way in which we perform procedures.”

As the field of interventional radiology evolves, and the number of complex procedures increases, new methods of teaching and learning—like simulation technology—are necessary.

“It’s unique that we’ve managed to create realistic images of the patient and biopsy needle together,” said Phillip Pratt, PhD, research fellow in the department of Surgery & Cancer at the Imperial College London and developer at the Digital Learning Hub. “This simulation is a great example of how mixed reality can help create learning environments that are interactive and challenging.”

Merit is proud to support medical training efforts with its high-quality products. Physicians of today and tomorrow can rely on these tools to learn new skills that will improve the lives of patients around the world.

Read the full Imperial College London article here.

Before using, refer to Instructions for Use for indications, contraindications, warnings, precautions, and directions for use.

For Katie, Dialysis Care Meant More Time with Her Mom

For Katie, Dialysis Care Meant More Time with Her Mom

For Katie, Dialysis Care Meant More Time with Her Mom
Strong, brave, selfless. These are just a few of the words Katie King used to describe her mother, Kay Lynn Welsh. After Kay passed away last year, Katie reached out to Merit Medical to express her gratitude for the hemodialysis care that gave her mother an additional 9 years of life with her family—something she never thought possible.

Katie’s story began the day Kay started hemodialysis in 2008. “She struggled to get a vascular access,” Katie recalled. “She had a failed graft and a failed fistula, and we had no other options.”

During this time a surgeon recommended the Merit HeRO® Graft, a hemodialysis access graft designed for patients like Kay who are failing conventional fistulas or grafts. “She either needed the HeRO, or she wouldn’t be with us,” Katie said. “After struggling in and out of the hospital, surgery after surgery, accesses failing, and her not feeling well, we pursued the HeRO, and it was successful. She got to enjoy life for nine years.”

Those nine years, Katie explained, were significant and happy ones for Kay and her family. Kay was able to attend both Katie’s and her husband’s graduations as well as see her become a dialysis nurse. She was there to see her granddaughter born and watch as her grandson graduated high school, become a marine, get married, and have a child of his own—making Kay a great grandmother.

“There are too many words to describe her,” Katie said. “She made me who I am today. We are so sad to be without her, yet so thankful for those nine years.”

Merit’s commitment to improving lives is what drives the innovation of products that help people like Kay live longer, providing hope to them and their families.

Merit Medical - How We're Maintaining Seamless and Uninterrupted Support

Merit Medical’s Commitment During COVID-19

Since 1987, Merit Medical has developed and delivered products that support healthcare providers and improve patients’ lives around the world. The Merit mission has been—and always will be—to understand, innovate, and deliver.

This moment in history is no different as the Merit team rises to meet current global healthcare challenges. Merit will unwaveringly continue to understand the needs of healthcare providers everywhere, innovate solutions, and deliver products and therapies to treat the patients who need them.

Every precaution possible is being taken to continue seamless and uninterrupted support during this time. A COVID-19 Operations Task Force meets daily to stay on top of all news and changes, so the Merit team can direct the organization appropriately.

MERIT REPRESENTATIVES VISITING HOSPITALS & PATIENT CARE FACILITIES

As hospital and patient care facilities place limitations on vendor visits, Merit representatives are prepared to continue to support these places per their specific guidelines, protocols, and restrictions, whether in person or virtually:

  • For essential vendor visits, Merit sales and clinical teams are following appropriate infection prevention protocols and are in constant communication with facilities to ensure protocols and policies are strictly followed.
  • All Merit field representatives will have FaceTime, WhatsApp, Google Duo, and Microsoft Teams to assist by video with product sales, in-services, training, and/or case support.
  • Training videos are already available for many Merit products and can be found on this site or upon request from sales representatives. If a video does not currently exist, one will be created upon request.

CUSTOMER SUPPORT

Merit’s Customer Service team is committed to supporting the needs of healthcare providers and will maintain longer-than-industry-average hours of operation. They may be reached at www.merit.com/customersupport.

PROTECTING OUR MANUFACTURING OPERATIONS & SUPPLY CHAIN

Merit utilizes a highly vertical supply chain and does not have manufacturing facilities in China. This extends from raw materials and pressure sensors to the innovative products and therapies healthcare providers depend on. Additionally, a diverse distribution structure has extensively prepared the company for a variety of scenarios.

Presently, COVID-19 has not caused any disruptions to Merit’s supply, operations, or delivery of products. The Merit team is taking every precaution to ensure that manufacturing operations and delivery remain uninterrupted and that ample product supply is available to continue to meet patient needs.

YOU ARE NOT ALONE

Merit is doing everything in its power to ensure that patients and healthcare providers are supported in every way possible. As the situation changes, ongoing updates will be posted to Merit homepage.

Please feel free to contact a Merit sales representative or the Customer Service team with any questions or comments.

MERIT’S JOURNEY THROUGH COVID-19

To share our step-by-step response to COVID-19, the Merit team has created a series of videos, each providing an in-depth look at important topics, such as how employees are protected during the pandemic, how each global facility maintains a safe work environment, how we are adapting to new customer protocols, and how numerous virtual initiatives have been implemented to provide seamless customer support.

 

Merit Celebrates International Women’s Day with Winning “W” Company Recognition

2020 Women on Board - Merit Medical Awarded a Winning "W" Company
 

This year Merit Medical celebrated International Women’s Day with a great honor. It was recognized as a Winning “W” Company for its commitment to board diversity. 2020 Women on Boards (2020WOB), a non-profit campaign dedicated to raising public awareness about the value of gender-diverse boards, awarded Merit for having at least 20% women on its board of directors. Currently, 30% (3 out of 10) of Merit’s Board of Directors are women.

Deepening cultural competence to enhance inclusivity in the workplace is a significant part of the Merit culture. Company-wide leadership training and education initiatives aim to not only increase awareness and knowledge but also encourage Merit leaders to bring out the best in team members, enabling everyone to work together.

According to 2020WOB, research has shown several advantages to public corporations having women on their boards, including higher profitability, productivity, and workforce engagement in comparison to boards with only men.1 Furthermore, having women directors helps to create and maintain a positive work environment for women and reinforces that the company values the contributions of women at all levels.1

Lucia Irazabal, a senior engineer, explains how working at Merit has helped her grow professionally and what International Women’s Day means for her and women everywhere.

Merit is committed to maintaining an inclusive workforce and understands that diversity leads to greater innovation, more opportunities, and a stronger team.

Learn more about how Merit fosters a culture of learning and growing by visiting the Diversity & Talent page.

Women on the Merit Medical Board of Directors

 
Jill Anderson - Merit Medical Board of Directors
Jill Anderson
F Ann Millner - Merit Medical Board of Directors
F. Ann Millner
Lynne Ward - Merit Medical Board of Directors
Lynne N. Ward

 

 


REFERENCES

1. 2020 Women on Boards. (2020). Why it matters. Retrieved from https://2020wob.com/about/why-it-matters/

Merit Medical Oncology - Supporting You During the COVID-19 Pandemic

Web-Based Resources During COVID-19

Merit Medical Oncology - Supporting You During the COVID-19 PandemicWe at Merit Medical are profoundly grateful for all that our healthcare partners are doing to support their patients and communities as we deal with the impact of COVID-19. Your efforts are truly heroic, delivering the highest quality, safe patient care during this challenging time.

We are taking every precaution possible to continue providing seamless and uninterrupted support. Our COVID-19 Operations Task Force is working around the clock to monitor developments and to respond appropriately to support our customers’ patient care and staff needs.

PHYSICIAN-TO-PHYSICIAN CONNECTIONS


Merit Café is an online, interactive forum connecting physicians across the county to share their experiences, challenges, best practices, and solutions with managing breast patients during COVID-19.

Vincent Reid, MD, Surgical Oncologist at Mercy’s Hall-Perrine Cancer Center in Cedar Rapids, Iowa was one of the first moderators of Merit Café and has joined us to discuss “The Impact of COVID-19 on Breast Cancer Management”. To read the full interview with Dr. Reid, click here.

CLINICAL CASE SUPPORT


Clinical case support is an integral part of our commitment to our SCOUT® and SAVI® customers. In this environment of restricted access, your Merit representatives are readily available to provide real-time case support via several easy-to-use platforms: Microsoft Teams, FaceTime or WhatsApp. We work closely with clinical teams to ensure a smooth and HIPAA compliant virtual support experience.

WEB-BASED LEARNING OPPORTUNITIES


Although in-person gatherings have been necessarily put on hold, we believe that learning opportunities for physicians should continue. As such, we will be hosting a series of webinars led by experienced physician faculty. These events will provide an opportunity to learn from and virtually connect with other physicians across the country around the latest in SCOUT Radar Localization and SAVI Brachytherapy.

CUSTOMER RESOURCES


We strive to ensure each customer is equipped with thorough and in-depth resources to support their use of SCOUT and SAVI technologies. Please contact your Account Executive for access to the SCOUT Customer Resource Portal, or any SAVI Brachy materials.

We at Merit are prepared to provide support and assistance through these trying times. If you have any questions or comments, please feel free to contact your local Account Executive or send an email.

Be assured that Merit is doing everything possible to ensure that healthcare providers and patients are supported as we navigate through this challenging time, together.

Home Dialysis Continues to Be a Nationwide Interest

Home Dialysis Continues to Be a Nationwide Interest

Home Dialysis Continues to Be a Nationwide Interest

Home dialysis remains in the U.S. spotlight, as seen in the December 2019 Nephrology News & Issues cover story “Home Dialysis Options Can Assist in Clinical Decision-Making.” Written by Stephen E. Hohmann, MD, FACS, one of Merit’s Think Dialysis Access™ proctors, the article discusses the advantages of home dialysis options, such as peritoneal dialysis (PD). Home dialysis became a topic of interest earlier in 2019 when the White House announced working on a new payment approach for treating kidney disease that favors home-based dialysis options.1

In the article, Dr. Hohmann suggests that advances in PD catheters and implantation systems have made the procedure and treatment more efficient. “Advances in PD catheters have facilitated more streamlined implantation while also potentially giving patients better dialysis fluidic dynamics,” he writes. “Catheters with a larger internal diameter (3.5 mm) compared to other on-market devices can be used, which allows for use of higher flow rates.”2

The catheters Dr. Hohmann refers to are Merit’s Flex-Neck® PD Catheters, the only PD catheters on the market with an inner diameter of 3.5 mm (except for infant-sized catheters). With a 3.5 mm inner diameter, the Flex-Neck is 35% larger than competitive catheters (at 2.6 mm ID), resulting in up to 30% higher flow rates.3 Higher flow rates can translate into reduced treatment times, allowing patients more freedom to do the things they love.

Dr. Hohmann mentions other home dialysis patient advantages that include “more profound improvements in blood pressure control, better kidney disease-related quality of life and shorter recovery time from dialysis treatments . . . compared to similar patients on in-center dialysis.”2 Such benefits are also associated with PD compared to in-center hemodialysis.2 The broader implementation of home dialysis PD care in particular has economic advantages. Dr. Hohmann explains that “a 5% increase in utilization of PD instead of in-center hemodialysis could save as much as $295 million annually.”2

With the increased emphasis on home dialysis, physicians and surgeons across the country are seeking training to support their transition to PD implantation. Merit has been proud to support this initiative with training as part of our Think Dialysis Access™ program, and we will continue rolling out opportunities throughout the upcoming year.

Explore Merit’s support for PD and home dialysis at Merit.com/PD.

Read the full December 2019 Nephrology News & Issues article here.


REFERENCES

  1. Copley, C., & Humer, C. (2019, March 3). U.S. seeks to cut dialysis costs with more home care versus clinics. Retrieved fromhttps://www.reuters.com/article/us-usa-healthcare-dialysis/us-seeks-to-cut-dialysis-costs-with-more-home-care-versus-clinics-idUSKCN1QL0G6
  2. Hohmann, S.E. (2019 Dec.). Home dialysis options can assist in clinical decision-making. Nephrol News Issues. Retrieved from https://www.healio.com/nephrology/kidney-care-community/news/print/nephrology-news-and-issues/%7Bdfac0f88-1d95-48bc-bc56-87070b4e611e%7D/home-dialysis-options-can-assist-in-clinical-decision-making
  3. Data on file.
Distal Transradial Access European ThinkRadial

Merit Medical at AACN National Teaching Institute (NTI) and Critical Care Expo 2019

Distal Transradial Access European ThinkRadial

Most Interventional Cardiologists throughout Europe support a radial-first approach for PCI. And more and more Interventional Radiologists and Neuro Radiologists admit that radial access plays a prominent role in an operator’s practice.

Merit Medical’s ThinkRadialTM program brings together these disciplines with one goal: leverage the benefits of using transradial access (TRA) in reduction of access-site complications and bleeding.1,2 In addition, a shorter hospital stay for the patient and therefore lower costs in most cases.3 Patient preference also plays a role: patients tend to prefer access via the wrist as opposed to their groin, and experience faster recovery.4

To enable physicians to benefit from TRA-practices, Dr. Ferdinand Kiemeneij (Interventional Cardiologist, The Netherlands) and Dr. Darren Klass (Interventional Radiologist, Canada) hosted another ThinkRadial program on June 28 and 29th in Maastricht, Netherlands. Dr. Ferdinand Kiemeneij, honoured at the 2018 EuroPCR meeting as one of the pioneers of the transradial approach for coronary catheterization and intervention (TRI), presented to the participants the left distal radial approach.

Physicians from 11 countries joined the programme to experience an effective combination of research-based learning and practical ‘tips and tricks’. After a mix of theory and practicing TRA procedures in simulation lab sessions and with cadavers, all participants left with the knowledge and skills needed to develop their own TRA practice in their hospital.

Distal Transradial Access European ThinkRadial
Distal Transradial Access European ThinkRadial

Interested in joining the ThinkRadial Community?

Merit Medical organizes ThinkRadial courses across the world. Please check here for the next course date. Looking forward to meeting you there!

Nigel Warren
Vice-President Peripheral Intervention EMEA


References

  1. Jolly, S. S., Yusef, S., Cairns, J., et al. (2011). Radial versus femoral access for coronary angiography and intervention for patients with acute coronary syndromes (RIVAL): A randomised, parallel group, multicentre trial. Lancet, Apr 23;377(9775):1409-1420.
  2. Valgimigli, M., Gagnor, A., Calabró, P., et al. (2015). Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: A randomised multicentre trial. Lancet, Jun 20;385(9986):2465-2476.
  3. Shroff, A. (Sept/Oct 2011). Economic opportunities of transradial angiography and intervention. Retrieved from https://citoday.com/2011/10/economic-opportunities-of-transradial-angiography-and-intervention
  4. Fischman, A. M., Swinburne, N. C., & Patel, R. S. (2015). A technical guide describing the use of transradial ac cess technique for endovascular interventions. Tech Vasc Interv Radiol, Jun;18(2):58-65.

Merit Medical Offers Full Range of Manual Bone Biopsy System Devices

Brighton Bipolar Probe®

The Brighton Bipolar Coagulation Probe is intended to be passed through an endoscope’s working channel to provide hemostasis throughout the gastrointestinal tract.


Advantages

  • Silver spiral electrode pair design provides constant power and thermal conductivity.
  • Hydrophilic coated tip can reduce probe adherence for more effective coagulation.
  • Round distal tip helps promote precise burn from various angles.
  • Unique catheter material facilitates passage through the endoscope and virtually eliminates kinking while providing optimum tamponade.
  • 350cm length offers one size to fit most endoscopes.
  • Dual and single plugs to fit most bipolar generators.
  • Irrigation through central lumen to effectively remove debris.
  • Purple color enhances positive endoscopic identification of the tip and catheter transition.
Brighton Bipolar Probe

Ordering Information

Catalog NumberDescriptionLengthGenerator Plug Type
BP-10F-DP-35010F (3.3mm)350cmDual
BP-10F-SP-35010F (3.3mm)350cmSingle
BP-7F-DP-3507F (2.3mm)350cmDual
BP-7F-SP-3507F (2.3mm)350cmSingle

Documents

Brighton Bipolar Probe Brochure®


Brighton Bipolar Coagulation Probe Instructions for Use (English)


Brighton Bipolar Coagulation Probe Instructions for Use (Multilingual)

WCIO

Merit Medical to Attend World Conference of Interventional Oncology 2017

Merit Medical is pleased to attend the Western Conference of Interventional Oncology (WCIO) in Boston from June 8-10.

WCIO will be conducting several workshops where you can view Merit products.

Friday, June 9 | 9:15-10:45am | MSK & Spine Interventions Saturday, June 10 | 9:15-10:45am | Ablative Therapies Saturday, June 10 | 1:30-3:00pm | Hepatic Intra-Arterial Therapies

To visit our booth, please stop by #510.

HeRO Graft - Hemodialysis Reliable Outflow

HeRO™ Graft Bypasses Central Venous Stenosis, Improves Hemodialysis

HeRO Graft - Hemodialysis Reliable Outflow

Central venous stenosis is a common and serious vascular complication among long-term hemodialysis patients that can lead to the loss of vascular access and a diminished life expectancy. To bypass venous stenosis and improve long-term hemodialysis adequacy, various permanent subcutaneous arteriovenous graft devices have been manufactured as a solution for hemodialysis patients who have exhausted all other access options.

One such product called the HeRO™ Graft was approved by the FDA in 2008. In comparison to catheters, it’s the only clinically proven permanent subcutaneous arteriovenous graft to reduce the risk of vascular access-related infections by 69%, improve adequacy of hemodialysis by up to 32% (1.7 Kt/V), and cut interventions needed to maintain access function by more than half.1 Studies have also linked the HeRO Graft to high cumulative patency rates that reach 87% at two years.2

Cost savings advantages have also been linked with using the HeRO Graft. A US healthcare model for provision of hemodialysis access predicted that in comparison to catheters, using the HeRO Graft could result in an average of 23% annual savings.3 Dialysis centers could save over $3000 per patient each year.4 And hospitals can save thousands in hefty admission costs that accrue because of device-related infections—rates that would commonly range between $23K to $56K per stay.5,6

What makes the HeRO Graft so unique?

Unlike other graft products, the HeRO Graft doesn’t depend on venous anastomosis to bypass venous stenosis. Instead, a radiopaque silicone Venous Outflow component reinforced with kink and crush-resistant nitinol braid is placed in the right atrium and securely attaches to an adjacent ePTFE hemodialysis graft by way of a proprietary titanium connector. This mechanism allows for blood to return from the arteries back to the heart.

To learn more about the HeRO Graft and how you can apply it to your practice, sign up for the upcoming Think HeRO training course held on March 30-31 at the Houston Methodist Institute for Technology, Innovation & Education (MITIESM) in Houston, Texas, by talking to your Merit representative or visiting Merit.com/Education

  1. Katzman, H., McLafferty, R., Ross, J., Glickman, M., Peden, E., & Lawson, J. (2009). Initial experience and outcome of a new hemodialysis access device for catheter-dependent patients. J Vasc Surg, 50(3): 600-607.e1.
  2. Gage, S., Katzman, H., Ross, J., Hohmann, S., Sharpe, C., Butterly, D., & Lawson, J. (2012). Multi-center experience of 164 consecutive Hemodialysis Reliable Outflow [HeRO] Graft implants for hemodialysis treatment. Eur J Vasc Endovasc Surg, 44(1): 93-99.
  3. Dageforde, L., Bream, P., & Moore, D. (2012). Hemodialysis Reliable Outflow (HeRO) device in end-stage dialysis access: a decision analysis model. J Surg Res, 177(1): 165-171.
  4. Yost, L., Dinwiddie, L. (2010, Nov.). Impact of the use of the HeRO vascular access graft vs. tunneled dialysis catheters on dialysis provider economics in an era of bundling. Poster session presented at ASN, American Society of Nephrology, Denver, CO.
  5. Ramanathan, V., Chiu, E., Thomas, J., Khan, A., Dolson, G., & Darouiche, R. (2007). Healthcare costs associated with hemodialysis catheter–related infections: a single‐center experience. Infect Control Hosp Epidemiol, 28(5): 606-609.
  6. O’Grady, N., Dellinger, E., Gerberding, J., Heartd, S. Maki, D., Masur, H., McCormick, R., Mermel, L., Pearson, M., Raad, I., Randolph, A., & Weinstein, R. (2002). Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics, 110(5): e51.
Merit Medical - American Heart Month 2020 - Merit is a Heart Company

American Heart Month at Merit

Evolving Embolotherapy at Merit with Modernized Gelatin Foam - Understand. Innovate. Deliver.

Merit Modernizes Gelatin Foam with Torpedo™ and EmboCube™ Embolotherapy Products

Merit Medical has a strong history of delivering high-quality embolics. For decades, our extensive embolotherapy portfolio has brought our customers a comprehensive line of clinically proven products made to streamline embolization procedures. Our embolotherapy offerings include a broad range of microspheres as well as nonspherical polyvinyl alcohol particles and gelatin foam products. A recent addition to our portfolio is the Torpedo, a new proprietary gelatin foam product indicated for the embolization of hypervascular tumors and bleeding in the peripheral vasculature. Along with EmboCube, another of our premium gelatin foam embolic agents with the same indications, our product offerings modernize preparation and delivery of gelatin foam by enabling speed, precision, and consistency.


SPEED

Torpedo and EmboCube were created to address preparation concerns associated with using traditional gelatin foam sheets. By making gelatin foam use faster, easier, and more efficient, physicians are able to focus more on the patient. To save physicians valuable time, Torpedo and EmboCube products only require hydration with a 50:50 saline-to-contrast mixture. Particles come uniformly cut, the Torpedo in a cylindrical shape and EmboCube in cubes, and both are preloaded, the Torpedo into a cartridge and EmboCube into a syringe. By eliminating the need for manual foam cutting, shaping, and loading into a delivery system, preparation is simplified when using Torpedo and EmboCube gelatin foam products.


PRECISION

Another challenge with manually cutting and shaping gelatin foam is that it results in inconsistently sized particles. Torpedo and EmboCube are available in two uniformly pre-cut sizes (2.5 mm and 5.0 mm diameters) and are designed for use with compatible catheters and microcatheters with inner diameters large enough to deliver the embolic material. These standardized sizes allow physicians to match the vasculature and achieve targeted embolization.


CONSISTENCY

Standardized particle sizes not only aid in achieving targeted embolization but also assist in proactively eliminating delivery challenges, such as particle aggregation in the catheter lumen. Inconsistently sized particles run the risk of clogging the delivery catheter. On the contrary, calibrated embolic particles, such as Torpedo and EmboCube gelatin foam, facilitate smooth catheter passage, helping to provide consistent and predictable results. Biocompatible and resorbable, Torpedo and EmboCube provide temporary yet durable mechanical occlusion.


Torpedo and EmboCube demonstrate Merit Medical’s commitment to ongoing innovation in the embolotherapy field. Providing safety, efficiency, and value to our embolotherapy customers enables them to reduce procedural time without compromising quality care.

Learn more about Torpedo and EmboCube gelatin foam products and explore our entire embolotherapy portfolio.

Please consult the product labels and inserts for any indications, contraindications, potential complications, warnings, precautions and directions for use.

Prepare For Your Angiography - Merit's Procedure Packs With Gowns - Merit Medical

Prepare for Angiography — Merit’s Procedure Trays With Gowns

Prepare for Angiography - Merit's Packs and Kits - Standard and Custom

Merit is aware of a disruption to the availability of custom procedural trays including AAMI level 3 surgical gowns provided by Cardinal Healthcare. We want to notify you that Merit Medical can quickly provide you with a suitable tray or pack replacement allowing you to perform critical diagnostic and interventional procedures. Cardinal is a valued partner in healthcare delivery to Merit Medical and our highest priority is to ensure that patients we mutually serve receive the care they need as quickly and efficiently as possible.

In addition to manufacturing medical devices for Interventional Cardiology and Radiology, Merit offers kits, packs, and trays in standard and custom configurations and assembles and distributes these to customers from a highly advanced and automated facility in Richmond, VA.

Merit’s Available Suggested Alternative:
Standard Angiography Tray, Catalog Number – K10T-03784

Of importance:

  • The above suggested tray is a suitable replacement for the majority of the affected packs that are used in Interventional Cardiology, Interventional Radiology, and Vascular Surgery.
  • Merit utilizes an ISO-certified manufacturer of level 3 gowns that are different from those affected.
  • If you require additional fluid administration items such as manifold kits, waste bags, Medallion® syringes, Merit can provide those items to ensure you have all of the products you need to complete cases.

TO LEARN MORE

Contact Customer Service
Phone: 801-208-4469
Email: [email protected]


Request Information

Please consult the product labels and inserts for any indications, contraindications, potential complications, warnings, precautions and directions for use.

Merit Medical - Your Partner in Drainage Solutions - Diverse, Innovative Drainage Solutions

With Ongoing Innovation, Merit Medical® Remains Your Partner in Drainage Care

Drainage Innovation Improves Patient Care - Aspira, ReSolve Mini, FastBreak - Merit Medical

Better drainage care stems from product innovation. By listening to valuable physician feedback and investing in technology that improves drainage care, Merit Medical is able to deliver products that meet unique clinical needs. Over the past two decades, we’ve expanded our drainage portfolio to include a diverse range of solutions that work together to help physicians achieve optimal drainage care.

ReSolve® Biliary Locking Drainage Catheter

Resolve BiliaryA common challenge associated with conventional biliary drainage catheters is that they offer only one hole pattern, often resulting in physicians making time-consuming modifications to facilitate better drainage.

Our ReSolve Biliary Locking Drainage Catheter, a complementary line to the ReSolve Non-Locking and Locking Drainage Catheters, is designed with two drainage hole patterns to manage both distal and proximal lesions as well as varying patient anatomy. Providing up to four times more drainage area,1 the ReSolve enables maximum drainage, delivering a targeted solution right from the start.

FastBreak™ Breakaway Connector

The FastBreak Breakaway Connector, a two-piece patient safety device, acts as a bridge between the drainage catheter and an external fluid reservoir, ensuring detachment occurs at the connector site instead of causing painful injury to the kidney or soft tissues. With the catheter, the FastBreak Breakaway Connector facilitates uninterrupted fluid flow and provide additional patient safety.

ReSolve ConvertX® Stent System

We understand physicians need devices that will simplify procedures and expand patient treatment options. ReSolve ConvertX is the only device that converts from a catheter to an internal ureteral or biliary stent without a second interventional procedure.

Not only does ConvertX intuitive technology provide a less invasive option for patients with severe ureteral or biliary obstructions, its biliary version makes it possible for interventional radiologists to place temporary plastic stents in patients who were previously not candidates.

Ureteral and biliary stent conversions are done in less than one minute during an office visit,1 reducing costs, time, and patient risk.2

Aspira® Drainage System

At Merit we transform drainage care into compassionate care with the Aspira® Drainage System, a home treatment option for end-stage cancer patients with malignant pleural effusion and malignant ascites.

Convenient and easy to use, the Aspira allows patients to spend more time at home by preventing frequent hospital visits to treat symptoms. It also helps eliminate hospital stays that may be required with other treatment options.

ReSolve Mini™ Locking Drainage Catheter

ReSolve Mini - Merit Medical - Up to 42% Smaller Than Standard Locking Pigtail CathetersThe ReSolve Mini Locking Drainage Catheter is the newest addition to our growing drainage portfolio. With the pigtail size up to 42% smaller than our ReSolve Locking Drainage Catheter pigtail, the ReSolve Mini creates the ideal solution for patients with smaller anatomy and smaller fluid pockets in the kidney and other areas. Read the full press release here.

Applying physician feedback has enabled us to create a better mini catheter compared to others on the market. Unlike competing catheters, the ReSolve Mini has a unique marker band to show drainage location, larger and more holes for maximum drainage, and better insertion force.1

Our investment in the drainage space shows our unwavering commitment to providing you with innovative devices that improve patient care. By understanding your drainage needs, we’ve built a comprehensive portfolio of products and accessories that work together to deliver superior performance and reliable quality. As your partner in drainage care, we look forward to hearing your ideas and transforming them into real-world solutions to your toughest clinical challenges.

Please consult the product labels and inserts for any indications, contraindications, potential complications, warnings, precautions and directions for use.



REFERENCES:
1. Data on file.
2. Due to eliminating an interventional exchange procedure.

Merit Tijuana - 1000 Employees - Merit Milestone Achieved

Merit Milestones: Facilities in Galway and Tijuana Reach 1,000 Employees

Since Merit Medical’s inception more than three decades ago, we have transformed from a US-based startup in Utah into a medical device powerhouse with facilities around the globe. Recently, we celebrated a proud moment for two of our locations. Merit Galway in Ireland and Merit Tijuana in Mexico both reached the 1,000-employee mark, a milestone that demonstrates expansion of our manufacturing capabilities and our growing capacity to meet customer needs.

“To be able to reach this goal of a thousand employees is an extraordinary accomplishment, especially if you go back and look at the beginning,” said Fred Lampropoulos, Merit Medical’s Chairman and CEO.

Merit Galway specializes in the design and manufacture of cardiology and peripheral-based access devices, navigation systems, and procedural kits. The facility’s strong reputation within the industry was recently recognized when it was honored as Medtech Company of the Year at the Irish Medtech Awards 2018. Thanks to a number of personal and professional development opportunities—such as improvement projects, a graduate program, well-being programs, and a social club—Merit Galway employees are able to grow with the company.

Learn more about our Galway team in this video.

The Tijuana facility is one of Merit’s manufacturing sites worldwide and produces a wide range of product lines, including drainage solutions, sheath introducers, disposal systems, and more. A team known for its dedication, hard work, and attention to detail, Merit Tijuana was the recipient of the prestigious Shingo Prize for Operational Excellence in 2019. Merit Tijuana employees are able to expand professionally through company-provided individual development plans and in-school certificate programs. They are also provided with unique benefits, such as transportation service to and from work and lunch at the facility’s award-winning café.

Merit Tijuana - 1000 Employees - Merit Milestone Achieved
Merit Tijuana - 1000 Employees - Merit Milestone Achieved

“My thanks to everybody for the effort and sustainability,” Lampropoulos said. “That’s always been the key to every part of our business. We’ve stayed the course.”

Join us in celebrating this company milestone and explore exciting career opportunities and employee benefits offered at each facility by visiting our Merit Facilities page.

Merit Galway - 1000 Employees - Merit Milestone Achieved
Merit Galway - 1000 Employees - Merit Milestone Achieved